Gimv is a European investment company with over three decades of experience in private equity and venture capital.
Gimv is listed on NYSE Euronext Brussels. Gimv currently manages around 1.8 billion EUR (including third party funds) of investments in 85 portfolio companies, which jointly realise a turnover of more than EUR 6 billion and employ
over 28,000 professionals.
As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv’s four investment platforms are: Consumer 2020, Health & Care, Smart Industries and Sustainable Cities. Each of these platforms works with a skilled and dedicated team across Gimv’s home markets of the Benelux, France and Germany and can count on an extended international network of experts.
More information on Gimv can be found on [www.gimv.com].
Website:www.gimv.com
Industries:
Biopharma
Manufacturing
Biotechnology
Health Care
Pharmaceutical
Advanced Materials
Chemical
Chemical Engineering
Energy
Industrial Automation
Medical Device
Therapeutics
EdTech
Education
Online Portals
Medical
Investor Types:
Venture Capital
Private Equity Firm
Investment Stages:
Late Stage Venture
Early Stage Venture
Location:
Belgium
Contact information: